Aerovate Therapeutics Board Member Maha Katabi Resigns
Company Announcements

Aerovate Therapeutics Board Member Maha Katabi Resigns

Aerovate Therapeutics ( (AVTE) ) has provided an announcement.

Maha Katabi, Ph.D., has resigned from Aerovate Therapeutics’ board of directors and its Audit and Compensation Committees, effective October 6, 2024. Her departure is voluntary and without any disputes related to the company’s operations or policies. The Board has expressed appreciation for Dr. Katabi’s service and contributions to the company.

See more insights into AVTE stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAerovate Therapeutics and Jade Biosciences Announce Strategic Merger
TheFlyAerovate Therapeutics, Jade Biosciences enter merger agreement
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App